Background {#Sec1}
==========

Urinary tract is protected against infections by several mechanisms unlike the kidney transplant patients are not. Despite significant advances in surgical techniques and immunosuppression, post-renal transplantation urinary tract infections particularly the bacterial origin continue to be a major public health problem globally with significant morbidity and mortality \[[@CR1]\]. Post-renal transplantation urinary tract infections squeal including asymptomatic bacteriuria, cystitis, and pyelonephritis are the most common form of bacterial infection following renal transplantation. These can occur at any time but with the highest incidence in the first 3--6 months after transplantation \[[@CR2]\].

The globally reported prevalence of post- renal transplantation urinary tract infection may vary depending the study design, immune suppression protocol, surgical protocol and diversity in the use of antimicrobial prophylaxis. However, incidence varies depending on the type of transplanted organ being the renal transplants are the highest risk groups among any other organ transplants \[[@CR3]--[@CR5]\].

In many countries of the world, kidneys are the most frequently transplanted organs to resolve end-stage renal disease. However, post-renal transplantation urinary tract infection has remained the leading cause of significant morbidity, mortality and graft failure, which reported globally. The clinical and socio-economic impacts are relatively higher in developing countries \[[@CR6], [@CR7]\]. The super imposed immune suppressions aimed to maintain the acute or chronic allograft rejection triggers antimicrobial selective pressure. In general, bacterial species leading to urinary tract infection in renal transplant recipients are similar to those causing UTIs in the general population. However, management in renal transplant recipients is undoubtedly more complex compared with the general population \[[@CR8], [@CR9]\]. The frequency of UTIs depends on many factors such as age, female gender, co-morbidities, immunosuppressive protocol and follow-up period \[[@CR3], [@CR10]--[@CR14]\].

Methods {#Sec2}
=======

Study design, area and period {#Sec3}
-----------------------------

A hospital-based cross-sectional study was conducted between December 2017 and August 2018 at St. Paul's Hospital Millennium Medical College at the National Kidney Transplantation Center.

Study population {#Sec4}
----------------

The study population were all adult kidney recipients aged ≥18 years who came for their check-up to the renal transplantation center suspected for both asymptomatic, symptomatic bacteriuria and who did not initiate of antibiotics therapy during the last 2 weeks and during data collection.

Sample collection {#Sec5}
-----------------

Seventy-four early morning 5 ml of midstream urine specimens were collected from all kidney recipients using wide-mouthed, sterile, leak-proof re-usable plastic containers following standard bacteriological procedures. All relevant data concerning socio-demographic characteristics, related risk factors to UTI, clinical signs and symptoms of the study participants were obtained using pre-designed structured questionnaires.

Bacterial culture and identifications {#Sec6}
-------------------------------------

Relevant data on the etiological agents were obtained using standard microbiological laboratory tests. The laboratory procedures were performed at clinical Bacteriology and Mycology laboratory located at National Reference Laboratory of the Ethiopian Public Health Institute, Addis Ababa, Ethiopia. All the laboratory procedures were performed using standard bacteriological procedures. Briefly, using calibrated wire loop One μl (0.001 ml) clean-catch midstream urine samples were inoculated into MacConkey (MAC) and 5% sheep blood agar plate (BAP) (Oxoid, UK). Then, cultures were incubated in the aerobic atmosphere at 35--37 °C for 24--48 h. Colonies were counted to check the presence of significant bacteriuria. Colony count yielding bacterial growth of ≥10^5^ cfu/ml of urine was considered significant bacteriuria according to the Infectious Diseases Society of America (IDSA) guidelines \[[@CR15]\]. All positive cultures with significant bacteriuria were then subjected to test identification to species level by their colony characteristics and patterns of biochemical profiles using standard bacteriological procedures \[[@CR3], [@CR16]\].

Antimicrobial susceptibility testing {#Sec7}
------------------------------------

Antibiotic susceptibility testing was performed for every significant positive culture following the manufacturer's instructions. Mueller-Hinton agar (Oxoid, UK) was used to do the susceptibility testing for the isolated bacteria. Isolates were classified as sensitive, intermediate and resistant according to the criteria of CLSI \[[@CR17]\].

Data quality control {#Sec8}
--------------------

The quality of culture media was tested for sterility and performance. Sterility of culture media was checked by incubating overnight at 35--37 °C without specimen inoculation. Standard reference strains of *E. coli* (ATCC 25922), *S. aureus* (ATCC 25923) and *P. aeruginosa* (ATCC 27853) were used for quality control throughout the study for culture and antimicrobial susceptibility test.

Data management and statistical analysis {#Sec9}
----------------------------------------

All the patient's records were anonymized by giving a number to each sample and questionnaire before the analysis and secured at all levels. All data were analyzed taking due to care for completeness, consistency, coding and sorting using SPSS (Statistical Package for Social Sciences) computer program (Version 20.0). Then, tables and texts were utilized to explain the descriptive data. In all cases, *P*-value \< 0.05 was taken as statistically significant. Furthermore, to assess any associated risk factors for post-renal transplant UTI, bivariate and multivariate logistic regression risk factor analysis was done to calculate crude/adjusted odds ratio and 95% confidence interval.

Ethical considerations {#Sec10}
----------------------

Ethical approval was obtained from the Department Ethics Research Committee (DERC), Department of Microbiology, Immunology, and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University (DERC committee's reference number: DERC/17/18/02-C). Subsequently, ethical approval was also obtained from St. Paul's Hospital Millennium Medical College (SPHMMC) Institutional Review Board (IRB reference number: P.m 23/409). Finally, the study secures at all levels and study participants were informed about the objective and benefit preceding the data collection procedure.

Results {#Sec11}
=======

Socio-demographic characteristics of studied participants {#Sec12}
---------------------------------------------------------

A total of 74 study participants (38 with symptoms and signs of UTI and 36 without symptoms and signs of UTI) were included in the study at St. Paul's Hospital Millennium Medical College. A majority, 42/74(56.8%) of them were males. The mean age was 41.55 years old with a standard deviation of 11.33 (41.55 ± 11.33) and a median of 40.5. Majority of the study participants 31(41.9%) were within the age group of 35--49 followed by 18--34(29/74, 39.2%) (Table [1](#Tab1){ref-type="table"}).Table 1Sociodemographic characteristics of study participants with and without UTI, St Paul's Hospital Millennium medical college, Addis Ababa, EthiopiaVariablesTotal (%)UTI no (%)No UTI no (%)Bivariate analysis*P*-valueCOR95%CIGender Male42 (56.8)5 (11.9)37 (88.1)0.8480.57--11.310.419 Female32 (43.2)6 (18.75)26 (81)2.091.04--8.450.253Age 18--3429 (39.2)4 (13.8)25 (86.2)1.420.64--14.050.338 35--4931 (41.9)6 (19.3)25 (80.6)3.672.89--20.070.003 50--6410 (13.5)1 (10)9 (90)32.91--10.000.914 Above 644 (5.4)0 (0.0)4 (100)0.880.58--3.270.444Marital status Single23 (31)6 (26.1)17 (74)5.640.73--13.220.222 Married30 (40.5)4 (13.3)26 (86.7)1.7241.081--6.820.391 Divorced12 (16.2)1 (8.3)11 (91.7)74.36--9.150.284 Widowed5 (6.8)0 (0.0)5 (100)0.230.11--3.740.058 Widower4 (5.4)0 (0.0)4 (100)8.042.05--10.090.701Educational level Student11 (14.9)2 (18.2)10 (91)10.37--4.120.348 Diploma31 (41)5 (16)26 (83.9)2.8720.81--5.060.579 Degree13 (17.6)2 (15)11 (84.6)42.01--6.190.441 Illiterate15 (20)2 (13)13 (86.7)2.111.90--17.480.990 Above degree4 (5.4)0 (0.0)4 (100)0.810.36--1.340.007

Clinical characteristics of study participants {#Sec13}
----------------------------------------------

The average time since transplantation in months was 38.4 ± 4.8 (Table [2](#Tab2){ref-type="table"}).Table 2Prevalence of UTI in related clinical variables of renal transplants recipientsVariablesTotal (%)UTI no (%)No UTI no (%)Bivariate analysis*p*-valueCOR95%CITime since transplantation 0--6 months17 (22.9)3 (17.6)14 (82.3)2.290.42--2.960.391 7--12 months19 (25.7)4 (21)15 (79)2.571.09--11.030.555 13--24 months19 (25.7)2 (10.5)17 (89.5)0.710.54--6.380.081  \> 24 months19 (25.7)2 (10.5)17 (98.5)1.230.98--7/110.661Pre- transplant UTI history Yes5 (6.8)2 (40)3 (60)4.322.09--17.100.010 No69 (93.2)9 (13)60 (87)0.510.26--2.110.997Place of the transplantation Local54 (73)9 (16.7)45 (83.3)4.010.18--19.060.481 Abroad20 (27)2 (10)18 (90)0.890.69--8.810.671Donor's gender Male40 (54.1)5 (12.5)35 (87.5)3.12.19--3.700.561 Female34 (45.9)4 (11.8)30 (88.2)2.071.04--7.310.549History of Catheterization Yes5 (6.8)1 (20)4 (80)1.901.11--11.380.001 No69 (93.2)10 (14.5)59 (85.5)0.530.21--0.980.941

Prevalence of significant bacteriuria among renal transplant recipients {#Sec14}
-----------------------------------------------------------------------

In the present study, significant bacteriuria was detected in 11/74 (14.9%) of the study participants investigated for urinary tract infection. In the meantime, the magnitude of significant bacteriuria has shown no association with the clinical signs and symptoms for post-renal transplantation urinary tract infection (Additional file [1](#MOESM1){ref-type="media"}: Table S1). *E.coli*, *P.mirabilis* and *Acinetobacter spp*. were exclusively found in asymptomatic patients (Additional file [2](#MOESM2){ref-type="media"}: Table S2).

Bacterial etiologies {#Sec15}
--------------------

A total of 11 bacteria (Table [3](#Tab3){ref-type="table"}) were isolated, out of these, 5 (45.4%) were Gram-negative bacteria and 6 (54.6%) were Gram-positive bacteria.Table 3Bacterial etiologic agents isolated from urine culture of renal transplantsBacterial isolatesFrequency(n)Percent (%)Gram-Negative545.4 *E.coli*218.2 *Acinetobacter spp.*218.2 *P.mirabilis*19.1Gram-positive654.6 *Enterococcus spp.*218.2 CoNS218.2 *S.aureus*218.2Total11100*CoNS* Coagulase-Negative *Staphylococci*

Antibiotic susceptibility data {#Sec16}
------------------------------

Clindamycin (67%) as shown in (Additional file [3](#MOESM3){ref-type="media"}: Table S3) and Gentamicin (100%) as shown in (Additional file [4](#MOESM4){ref-type="media"}: Table S4) were the most effective antibiotic among the groups against the Gram-positive and negative bacterial isolates respectively. Multidrug resistance (resistance in ≥3 drugs) was seen in 82% of the isolates among diagnosed renal transplant recipients.

Discussion {#Sec17}
==========

Urinary tract infections mainly the bacterial origin are the most common infectious complication especially to kidney transplant recipients \[[@CR18], [@CR19]\]. Both formidable and none formidable associated risk factors are the leading consequences to either the allograft survival or patient survival besides the socioeconomic burdens. Influence of immunosuppression that leave the patient immune quell are top priority in many clinical settings \[[@CR20]--[@CR22]\].

The present study revealed that the majority (56.8%) of study participants were males. However, higher number of females were affected by post -renal transplantation UTI than males (18.75% versus 11.9% respectively) with insignificant association. In harmony to the present study, a research paper by Kotagiri et al., \[[@CR23]\] in Australia, Shams et al.*,* \[[@CR24]\] in Iran and Bispo et al.*,* \[[@CR25]\] in Portugal has shown that a large number of females were affected (*P* = 0.002, *P* \< 0.001 and *P* \< 0.005 respectively). Unlike to the present finding, study from Yemen by Gondos et al., \[[@CR14]\], Portugal by Bispo et al.*,* \[[@CR25]\] and Saudi Arabia by Alkatheri, \[[@CR26]\] higher female prevalence of UTI (female 40.3%, males 29%, female 68%, male 23% and female 69.2%, male 30.8% respectively) were reported with no statistically significant association. This may be due to women are more susceptible to UTIs, which results from anatomical, hormonal, immunological and behavioral features \[[@CR27]--[@CR30]\].

In the present study, the overall bacterial UTI was found 14.9% of the patients (95% CI = 8.2--24.7). The present prevalence was quite smaller than the recent reports from different parts of the world. Shams et al.*,* \[[@CR24]\] in Iran, Becerra et al., \[[@CR29]\] in the USA, Menegueti et al., \[[@CR31]\] in Brazil, Elkehili et al., \[[@CR32]\] in Libya and Ooms et al., \[[@CR33]\] in Netherland reported as 22.7, 28, 26.2, 29.5 and 28%, respectively. On the other way, the highest incidence of UTI among renal transplant recipients was also reported by Khosravi et al., \[[@CR7]\] in Iran, Gondos et al., \[[@CR14]\] in Yemen, Alkatheri, \[[@CR26]\] in Saudi Arabia that was 33.56, 33.5 and 55.5% respectively. However, the current result was nearly similar to reported results from Portugal (16.5%) by Bispo et al., \[[@CR25]\] but much higher than the report by Kotagiri et al., \[[@CR23]\] in Australia (8%). This significant variation in UTI reported rates might be due to local ascribe of outbreaks, center-specific potent immunosuppressive therapy, lack of the robust definition of UTI and study designs in many clinical settings \[[@CR34]\].

In the present study, the multivariate logistic regression has shown that 35--49 age groups (*P* = \< 0.001, adjusted odds ratio = 2.61, 95%CI = 2.06--18.19), the previous history of pre-transplantation UTI (*P* = 0.02, adjusted odds ratio = 3.48, 95%CI = 2.12--9.38) and the previous history of catheterization (*P* = 0.003, adjusted odds ratio = 3.29, 95% CI = 2.05--11.85) were associated risk factor. In line to the present report Bispo et al., \[[@CR25]\] and Kumar et al.*,* \[[@CR30]\] have shown the presence of pre-transplant UTI history as a risk factor for post-transplant UTI. Discordant to the present finding, Ooms et al., \[[@CR33]\] unveiled that older age groups (\> 65 years old) were the risk factors for post renal transplantation UTI (*P* = \< 0.001, AOR = 3.58, 95%CI = 2.16--5.91). This discrepancy may be due to study design and impact of potent immunosuppressive drugs \[[@CR35], [@CR36]\].

In the contemporary study, the most prevalent bacteria isolates causing post-renal transplant UTI were *Escherichia coli* (18.18%), *Acinetobacter spp*.(18.18%), *P. mirabilis* (9.1%), *S. aureus* (18.18%,), *Enterococcus spp*. (18.18%), Coagulase-negative *Staphylococci* (18.18%). This result is incomparable with recently published research paper by Gozdowska et al., \[[@CR1]\]); *E.coli* (42%) and *Enterococcus spp*. (10%). Similarly, the current finding dissimilar to a retrospective study done by Kotagiri et al., \[[@CR23]\] that found *E.coli* (32%) and *Enterococcus spp*.(35%) which were responsible for post- renal transplantation UTI. In addition, another study unveils that *E. coli* (46%), *P. mirabilis* (26%), *S. aureus* (25.8%) and Coagulase-negative *Staphylococci* (6.8%) were etiologies of post-renal transplantation UTI which were relatively higher than the present result except to Coagulase-negative *Staphylococci* \[[@CR37], [@CR38]\]. The present finding was discordant with Elkehili et al., \[[@CR32]\] that ciprofloxacin (51.6%), followed by amoxicillin-clavulanic acid (22.6) were choices of drug for the Gram-negative. This could be justified by bacterial antibiotic prophylaxis selection should have adhered to conventional urinary culture so that prophylaxis should be tailored based on appropriate antibiogram batteries. In addition, disparities with present findings may be due to the lack of access of antibiotics, selection of antimicrobial agents and antibiotic stewardship program \[[@CR14], [@CR39]--[@CR43]\].

In the present study, multi drug-resistant strains was seen in 82% of the isolated bacteria. This is similar to the current study done by Yuan et al., \[[@CR39]\] in China, which reported 86.4%. Gozdowska et al., \[[@CR1]\] and Bodro et al., \[[@CR41]\] were reported much lower than our finding (37%). This is a threat to kidney transplants because it increases health care costs, prolongs hospital stays and can result in treatment failure \[[@CR44]--[@CR46]\].

Conclusions {#Sec18}
===========

In conclusion, the overall prevalence of UTI in our population was relatively low with a prevalence of 14.9%. Majority of the UTIs were asymptomatic. A higher percentage of females were involved. Intensive longitudinal research activities to identify the risk factors as well as to elucidate the existing controversies of post-renal-transplantation UTI over allograft outcome are highly demanding. In countries like Ethiopia where the resources are limited especially of advanced diagnostic facilities to screen and monitor renal transplants, it is better to establish routine urine cultures especially in the first 6--12 months after kidney transplantation for recipients on follow up. The current study is indicating the evolution of multidrug-resistant isolates among kidney transplants. To endorse judicious treatment, careful and systemic selection of antimicrobial agents together with rigorous infection preventions and control strategies should be employed to mitigate both hospital and community-acquired Urinary tract infections.
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